Home-Based Care for Patients with Lysosomal Storage Disease: Experiences in Argentina
View/ Open
Date
2019-07-01Author
Brunelli, Maria Victoria.
Rabhansl, Maria.
Delacre, Clara.
Dankert, Maria.
Cuevillas, Maria.
Frias, Catalina
Metadata
Show full item recordAbstract
ABSTRACT
Enzyme replacement therapy (ERT) is a long term treatment for patients who suffer from lysosomal storage disease. A transversal
descriptive study was conducted to evaluate advantages and disadvantages of a home-based care program for patients with Gaucher,
Fabry and Mucopolysaccharidosis II (MPS II) diseases. A survey among patients and nurses involved in healthcare delivery at home
was utilized for this study. The adherence rate was 92.9% over the study period. Eighty six point nine percent chose to carry
out the treatment at home and 88.5% felt that their quality of life had improved. Additional advantages reported were: comfort
(77%), treatment adjustment to daily activities (69%) and flexibility (58%). Disadvantages expressed were: lack of confidence with
the health care provider at home (1.6%) and a shortage of disposable materials available (1.6%). The main benefits of home-based
treatment were the high treatment adherence and the improvement in quality of life.